BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q1 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,567,381 | +2.1% | 88,065 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $9,370,482 | -10.8% | 86,820 | +3.0% | 0.00% | 0.0% |
| Q1 2023 | $10,502,745 | +83801.1% | 84,312 | +1.2% | 0.00% | -50.0% |
| Q4 2022 | $12,518 | -99.9% | 83,332 | +4.9% | 0.00% | 0.0% |
| Q3 2022 | $10,717,000 | -7.0% | 79,462 | +2.8% | 0.00% | 0.0% |
| Q2 2022 | $11,523,000 | +2.3% | 77,290 | +17.0% | 0.00% | +100.0% |
| Q1 2022 | $11,263,000 | -33.7% | 66,040 | +0.2% | 0.00% | -50.0% |
| Q4 2021 | $16,984,000 | +5.6% | 65,882 | +11.8% | 0.00% | 0.0% |
| Q3 2021 | $16,085,000 | +25.9% | 58,924 | +3.3% | 0.00% | 0.0% |
| Q2 2021 | $12,775,000 | +109.8% | 57,064 | +2.3% | 0.00% | +100.0% |
| Q1 2021 | $6,088,000 | +55.2% | 55,760 | +15.9% | 0.00% | 0.0% |
| Q4 2020 | $3,923,000 | +41.9% | 48,125 | +20.5% | 0.00% | 0.0% |
| Q3 2020 | $2,765,000 | +529.8% | 39,947 | +506.5% | 0.00% | – |
| Q2 2020 | $439,000 | +24.4% | 6,586 | +8.9% | 0.00% | – |
| Q1 2020 | $353,000 | – | 6,046 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |